Gene study reveals clues about ulcerative colitis and drug effectiveness
NCT ID NCT07564895
First seen May 14, 2026 · Last updated May 23, 2026 · Updated 2 times
Summary
This completed study examined whether differences in the BAFF gene are linked to the risk of developing ulcerative colitis and how well the drug vedolizumab works. Researchers analyzed DNA from 841 people with ulcerative colitis to identify gene patterns. The goal was to better understand the disease and potentially guide future treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS (UC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
the Second Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
Conditions
Explore the condition pages connected to this study.